Factors Influencing Marker Expressions of Cultured Human Cord Blood-Derived Mast Cells

被引:4
|
作者
Alimohammadi, Shahrzad [1 ,2 ]
Masuda-Kuroki, Kana [1 ]
Szollosi, Attila Gabor [2 ,3 ]
Di Nardo, Anna [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Dermatol, La Jolla, CA 92037 USA
[2] Univ Debrecen, Doctoral Sch Mol Med, H-4032 Debrecen, Hungary
[3] Univ Debrecen, Fac Med, Dept Immunol, H-4032 Debrecen, Hungary
关键词
human stem cells; CD34(+) cord blood-derived mast cells; immune response; c-KIT; Fc epsilon RI; MRGPRX2; TLR2; tryptase; chymase; SI-LOCUS; INFLAMMATION; RECEPTOR; GROWTH; LIGAND; IL-4;
D O I
10.3390/ijms241914891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mast cells (MCs) are tissue-resident immune cells of a hematopoietic origin that play vital roles in innate and adaptive immunity. Human MCs can be isolated and differentiated from various tissue sources, including cord blood, when supplemented with cytokines such as stem cell factor, interleukin 3, and interleukin 6. Our current research study has shown significant differences in the marker expressions of human cord blood-derived mast cells (hCBMCs) based on donor dependency and the type of medium used for culturing and differentiation. These findings are particularly relevant given the challenges of obtaining specialty media influencing MC phenotypic marker expressions. We found that hCBMCs cultured in StemSpanTM-XF medium had a moderate expression of mast/stem cell growth factor receptor Kit (c-KIT) (mRNA and protein), low expressions of Fc epsilon RI (mRNA) and TLR2 (mRNA and protein) but had high levels of MRGPRX2 (mRNA and protein) expressions. In contrast, hCBMCs cultured in Stem Line II medium expressed Fc epsilon RI and TLR2 (mRNA and protein) with higher c-KIT but had lower MRGPRX2 expressions compared to the hCBMCs cultured in the StemSpanTM-XF medium. These results suggest that it is crucial to consider both donor dependency and the medium when investigating MC functions and that further research is needed to fully understand the impact of these factors on the hCBMC marker expressions.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Safety of hopoxia-cultured human umbilical cord blood-derived mesenchymal stem cells: subchronic toxicity, tumorigenicity
    Kwon, E.
    You, J.
    Yoon, J.
    Kang, B.
    TOXICOLOGY LETTERS, 2018, 295 : S227 - S227
  • [42] Effects of hypoxia on proliferation of human cord blood-derived mesenchymal stem cells
    Peng, Longying
    Shu, Xiaomei
    Lang, Changhui
    Yu, Xiaohua
    CYTOTECHNOLOGY, 2016, 68 (04) : 1615 - 1622
  • [44] Effects of hypoxia on proliferation of human cord blood-derived mesenchymal stem cells
    Longying Peng
    Xiaomei Shu
    Changhui Lang
    Xiaohua Yu
    Cytotechnology, 2016, 68 : 1615 - 1622
  • [45] Genomic investigation of the metabolic competency of human cord blood-derived dendritic cells
    Pendlington, Ruth U.
    Summerfield, Vicki
    White, Andrew
    Pease, Camilla K.
    TOXICOLOGY, 2007, 231 (2-3) : 107 - 108
  • [46] Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells
    Mayani, H
    Lansdorp, PM
    STEM CELLS, 1998, 16 (03) : 153 - 165
  • [47] Immunotherapy of Human Neuroblastoma Using Umbilical Cord Blood-Derived Effector Cells
    Avadhut D. Joshi
    Erin M. Clark
    Peng Wang
    Corey M. Munger
    Ganapati V. Hegde
    Sam Sanderson
    Harish P. G. Dave
    Shantaram S. Joshi
    Journal of Neuroimmune Pharmacology, 2007, 2 : 202 - 212
  • [48] Human umbilical cord blood-derived mesenchymal stem cells and their effect on gliomas
    Shankar, S. K.
    NEUROLOGY INDIA, 2011, 59 (02) : 226 - 228
  • [49] Human cord blood-derived cells attain neuronal and glial features in vitro
    Buzanska, L
    Machaj, EJK
    Zablocka, B
    Pojda, Z
    Domanska-Janik, K
    JOURNAL OF CELL SCIENCE, 2002, 115 (10) : 2131 - 2138
  • [50] Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells
    Joshi, Avadhut D.
    Clark, Erin M.
    Wang, Peng
    Munger, Corey M.
    Hegde, Ganapati V.
    Sanderson, Sam
    Dave, Harish P. G.
    Joshi, Shantaram S.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2007, 2 (02) : 202 - 212